ApalyRx: Turn-Key Direct-to-Employer Infrastructure for Manufacturers

Manufacturers lose 40-60% of WAC to wholesaler margins, PBM spread, and rebate float held 90-180 days. No pricing control past the loading dock. No visibility into which employers actually receive their drug.

ApalyRx changes that.

We are the patent-pending, end-to-end platform that brings manufacturer direct-to-employer programs inside the employer benefit, without changing how manufacturers currently operate or ship.

Manufacturers gain pricing control to the point of dispense, real-time member-level data, locked employer formulary position, and rebates applied at dispense rather than held 90-180 days. Safety stock requirements drop dramatically against a known enrolled member census.

On the employer side, the drug lands in-benefit with full cost-share collection and claims settlement through either the employer's TPA or existing PBM. We work with the PBM. We are not a replacement.

No wholesaler. No distributor spread. No change to how manufacturers currently ship.

Every routing decision produces an independently verifiable record, proof the drug benefit operated with integrity.

apalyrx.com | jerry@apalyrx.com

Apaly Rx

Jerry Beinhauer MD

This department oversees the strategic direction and management of all marketing initiatives within the organization.

Apaly Rx

Org chart

Teams

Marketing Leadership

Offices

Apaly Rx

Org chart

Teams

Marketing Leadership

Offices

Related companies